Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 24, 2023

SELL
$145.48 - $175.02 $94,416 - $113,587
-649 Reduced 3.53%
17,758 $2.96 Million
Q4 2022

Feb 13, 2023

BUY
$131.14 - $157.47 $380,568 - $456,977
2,902 Added 18.72%
18,407 $2.7 Million
Q3 2022

Nov 04, 2022

BUY
$148.29 - $182.55 $102,468 - $126,142
691 Added 4.66%
15,505 $2.3 Million
Q2 2022

Aug 10, 2022

BUY
$155.97 - $200.09 $54,901 - $70,431
352 Added 2.43%
14,814 $2.55 Million
Q1 2022

May 04, 2022

BUY
$181.39 - $234.03 $2.62 Million - $3.38 Million
14,462 New
14,462 $2.73 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Legacy Cg, LLC Portfolio

Follow Legacy Cg, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Cg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Cg, LLC with notifications on news.